IL DONG PHARMACEUTICAL CO., LTD.
Develops, manufactures, and commercializes a broad range of healthcare products.
249420 | KO
Overview
Corporate Details
- ISIN(s):
- KR7249420001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 2, 서초구
- Sector:
- Manufacturing
Description
IL DONG PHARMACEUTICAL CO., LTD. is a pharmaceutical company engaged in the research, development, manufacturing, and commercialization of a broad range of healthcare products. The company's portfolio encompasses ethical drugs, over-the-counter (OTC) medications, active pharmaceutical ingredients (APIs), and health functional foods. Key therapeutic areas of focus include metabolic disorders, gastrointestinal diseases, degenerative diseases, oncology, and cardiovascular conditions. Its robust research and development pipeline features promising drug candidates such as an oral GLP-1 receptor agonist for diabetes and obesity, a P-CAB class treatment for peptic ulcers, and a first-in-class CXCR7 agonist for fibrotic diseases. Utilizing its GMP-certified facilities, the company also offers contract manufacturing (CMO) services, with specialized capabilities in antibiotics and oncology drugs, while actively pursuing global expansion through strategic partnerships and licensing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-03-12 00:00 |
감사보고서제출
|
Korean | 22.0 KB | ||
| 2020-03-05 00:00 |
[기재정정]현금ㆍ현물배당결정
|
Korean | 16.4 KB | ||
| 2020-03-05 00:00 |
[기재정정]영업(잠정)실적(공정공시)
|
Korean | 20.5 KB | ||
| 2020-03-05 00:00 |
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 22.6 KB | ||
| 2020-03-05 00:00 |
주주총회소집공고
|
Korean | 716.3 KB | ||
| 2020-03-05 00:00 |
[기재정정]주주총회소집결의
|
Korean | 19.1 KB | ||
| 2020-03-05 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB | ||
| 2020-02-14 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 14.7 KB | ||
| 2020-02-14 00:00 |
기업설명회(IR)개최(안내공시)
|
Korean | 6.7 KB | ||
| 2020-02-14 00:00 |
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 17.4 KB | ||
| 2020-02-14 00:00 |
주요사항보고서(무상증자결정)
|
Korean | 8.7 KB | ||
| 2020-02-14 00:00 |
현금ㆍ현물배당결정
|
Korean | 9.2 KB | ||
| 2020-02-14 00:00 |
주주총회소집결의
|
Korean | 12.6 KB | ||
| 2020-02-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 15.6 KB | ||
| 2020-02-11 00:00 |
결산실적공시예고(안내공시)
|
Korean | 4.6 KB |
Automate Your Workflow. Get a real-time feed of all IL DONG PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IL DONG PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IL DONG PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
